Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
11
×
boston blog main
boston top stories
biotech
national top stories
clinical trials
new york blog main
deals
new york top stories
san diego blog main
san diego top stories
san francisco blog main
fda
raleigh-durham blog main
san francisco top stories
raleigh-durham top stories
startups
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
intercept pharmaceuticals
national
new york
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alexion pharmaceuticals
boston
celgene
What
disease
11
×
drug
11
×
medicines
approved
fda
liver
new
year
bio
deal
fatty
gene
help
hepatitis
infectious
known
medicine
nash
patients
pharma
pharmaceuticals
race
rare
roundup
stop
therapeutics
therapy
treatment
acorda
adds
advanced
ago
akcea
alliance
alnylam
alnylam’s
alternative
alzheimer's
amyloidosis
approval
Language
unset
Current search:
disease
×
drug
×
" national blog main "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed